385 related articles for article (PubMed ID: 29529336)
1. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
PelvEx Collaborative
Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
[TBL] [Abstract][Full Text] [Related]
2. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
PelvEx Collaborative
Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
[TBL] [Abstract][Full Text] [Related]
3. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
4. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
[TBL] [Abstract][Full Text] [Related]
5. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
[TBL] [Abstract][Full Text] [Related]
6. Survival after pelvic exenteration for T4 rectal cancer.
Kusters M; Austin KK; Solomon MJ; Lee PJ; Nieuwenhuijzen GA; Rutten HJ
Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182
[TBL] [Abstract][Full Text] [Related]
7. Determinants of survival following pelvic exenteration for primary rectal cancer.
Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
[TBL] [Abstract][Full Text] [Related]
8. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
Westberg K; Palmer G; Hjern F; Holm T; Martling A
Br J Surg; 2019 May; 106(6):790-798. PubMed ID: 30776087
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
10. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
11. Persistent involvement of anterior mesorectal fascia in carcinoma rectum - extended resection of rectum vs total pelvic exenteration: results from a single-centre retrospective study.
Verma K; Engineer R; Ostwal V; Kumar S; Arya S; Desouza AL; Saklani AP
Colorectal Dis; 2018 Dec; 20(12):1070-1077. PubMed ID: 29985547
[TBL] [Abstract][Full Text] [Related]
12. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
13. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
[TBL] [Abstract][Full Text] [Related]
14. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
[TBL] [Abstract][Full Text] [Related]
15. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
16. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
17. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
[TBL] [Abstract][Full Text] [Related]
18. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival.
Sasikumar A; Bhan C; Jenkins JT; Antoniou A; Murphy J
Dis Colon Rectum; 2017 Mar; 60(3):346-352. PubMed ID: 28177998
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenteration for advanced malignancy in elderly patients.
Radwan RW; Evans MD; Davies M; Harris DA; Beynon J;
Br J Surg; 2016 Jan; 103(2):e115-9. PubMed ID: 26662618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]